Learn more about a wide variety of topics concerning drug discovery and drug development via the video resources below.
April 13, 2020
Since different polymorphs have different physicochemical properties, identifying a viable polymorph early during the drug development is essential. By end of Phase II, knowledge about the solid state form should be provided to the FDA including the propensity to exhibit polymorphism along with other physicochemical data. Regis can help you […]
April 14, 2020
Quantitative NMR (qNMR) is a powerful stand-alone method for the determination of purity and potency in the field of pharmaceutical/ biotech development; it is rapid, accurate, and economical. Check out this short informative presentation on qNMR and how Regis plans to implement this new purity determining technology! (9 minutes)
April 10, 2020
Filing an Investigational New Drug (IND) application with FDA is a milestone for emerging pharmaceutical companies seeking to gain approval for clinical testing of innovative new therapies. The IND application process must be thorough and by the book; collecting and reporting the supporting chemistry, manufacturing, and control (CMC) information can […]